By Brendan Pierson ( May 20, 2008, 12:00 AM EDT) -- A judge knocked out a major part of Abbott Laboratories' defense against an antitrust suit related to its HIV treatment Norvir, ruling Friday that claims in two of Abbott's patents for a method of combining Norvir with other protease inhibitors are invalid....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.